Moi University Open Access Repository

A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment

Show simple item record

dc.contributor.author Kimaiyo Sylvester
dc.contributor.author Paula Braitstein
dc.contributor.author Siika Abraham
dc.contributor.author Hogan Joseph W
dc.contributor.author Sang Edwin
dc.contributor.author Kosgei Rose
dc.contributor.author Sidle John
dc.contributor.author Kara K Wools-Kaloustian
dc.contributor.author Keter Alfred
dc.contributor.author Mamlin Joseph
dc.date.accessioned 2019-02-06T07:59:59Z
dc.date.available 2019-02-06T07:59:59Z
dc.date.issued 2012-02-17
dc.identifier.uri http://ir.mu.ac.ke:8080/xmlui/handle/123456789/2663
dc.description.abstract Background In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. Methods The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm3. All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm3 were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. Results Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm3. After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). Conclusions Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings. en_US
dc.language.iso en en_US
dc.publisher Journal of the International AIDS Society en_US
dc.subject Antiretrovirals en_US
dc.subject Mortality en_US
dc.subject Losses to follow up en_US
dc.subject Adherence en_US
dc.subject Models of care en_US
dc.subject Africa en_US
dc.title A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account